We are honoured to announce that we have joined forces with the European Renal Association- European Dialysis and Transplant Association (ERA-EDTA) to bring together expert Hepatologists and Nephrologists to eliminate viral hepatitis among patients with chronic kidney disease (CKD).

Professor Michel Jadoul, who is jointly leading this initiative with Professor Stanislas Pol, said “The burden associated with HCV (mortality, morbidity and quality of life) remains substantial in CKD, dialysis and kidney transplant patients . Fortunately, very recent studies extend the dramatic improvement of the treatment of hepatitis C to CKD populations . Thus, there should be no reason for complacency anymore. Success is now at hand, under the partnership of key actors in the field of liver and kidney diseases.”

The initiative will kick-off on November 1st in conjunction with the Kidney Week Meeting in New Orleans. Together, we aim to not only kick-start the call to action but provide the information, training, tools, and strategic guidance to radically alter the prevention and treatment of viral hepatitis in this vulnerable population.

Data Protection and Privacy Policy

EASL International Liver Foundation

We take the protection of your personal data seriously, meaning that we process your personal data with due care and in accordance with applicable data protection laws.

Consent

Please note that by clicking the box “I agree”, you explicitly agree to the processing of your personal data for the purposes and pursuant to the terms and conditions mentioned in our Data Protection and Privacy Policy available at here“.

Contact

For any question or request, please contact us at EASL International Live Foundation, Rue Daubin 7, 1203 Geneva, Switzerland, telephone 0041 (0)22 552 2497 gdpr@easl-ilf.org